(Q48466243)

11 February 2018

title

Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. (English)

1 reference

11 February 2018

0 references

Dawson LA

1

1 reference

11 February 2018

Nguyen HQ

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

11 February 2018

European Journal of Pharmacology

published in

1 reference

11 February 2018

volume

345

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

41-46

1 reference

11 February 2018

Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Current advances and trends in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Neurobiological mechanisms involved in antidepressant therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901580-X

10.1016/S0014-2999(97)01580-X

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9593592

1 reference

11 February 2018